(Q42285750)

English

Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma.

scientific article published on 20 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

chronic hepatitis B

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Meirong Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ning Qiu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Shichun Lu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Dianrong Xiu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jianguo Yu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Xing Tai Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Fengmin Lu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Tong Li

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hui Zhuang

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

20 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

85

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

219-227

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Hepatitis B virus infection--natural history and clinical consequences

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Benefits and risks of interferon therapy for hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Development of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42285750&oldid=1569268100"